FAKTOR OPTIONSSCHEIN - FRESENIUS MEDICAL CARE Share Price

Certificat

DE000HC283W6

Real-time BOERSE MUENCHEN 01:16:59 05/06/2024 am IST
1.31 EUR 0.00% Intraday chart for FAKTOR OPTIONSSCHEIN - FRESENIUS MEDICAL CARE
1 month-11.49%
3 months-50.75%
Date Price Change
04/24/04 1.31 0.00%
03/24/03 1.31 0.00%
31/24/31 1.31 -0.76%
30/24/30 1.32 -5.04%
29/24/29 1.39 +6.92%

Real-time BOERSE MUENCHEN

Last update June 05, 2024 at 01:16 am IST

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying FRESENIUS MEDICAL CARE AG
IssuerLogo Issuer UniCredit UniCredit
WKN HC283W
ISINDE000HC283W6
Date issued 30/11/2022
Strike 52.19
Maturity Unlimited
Parity 10.23 : 1
Emission price 10.04
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 10.45
Lowest since issue 1.11
Spread 0.01
Spread %0.78%

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
39.14 EUR
Average target price
39.97 EUR
Spread / Average Target
+2.13%
Consensus